Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review - Report - MDSpire

Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review

  • By

  • Jelle C. B. C. de Jong

  • Milou G. W. Lentjes

  • Karleen F. Pietersma

  • Wilrike J. Pasman

  • Suzan Wopereis

  • Femke P. M. Hoevenaars

  • July 15, 2026

Share

Clinical Report: Enhancing Endogenous GLP-1 Secretion and Satiety Through Dietary Fibers

Overview

This scoping review evaluates the effects of dietary fibers on endogenous GLP-1 secretion and satiety. Dextrins emerged as a promising fiber type, showing positive effects on both outcomes.

Background

Dietary fibers can stimulate GLP-1 secretion, which is crucial for appetite regulation and weight management. Understanding the relationship between fiber types and GLP-1 responses is essential for developing effective dietary recommendations.

Data Highlights

Study TypeNumber of StudiesParticipantsMedian Sample Size
Acute Interventions521,08519

Key Findings

  • 49 publications comprising 52 studies were included in the review.
  • 71% of studies were acute interventions conducted in Western populations.
  • Dextrins showed effects on both GLP-1 and satiety with 4 and 5 positive studies, respectively.
  • Other fibers like β-glucans and mannans had more uniform effects but did not consistently affect both GLP-1 and satiety.
  • Studies reporting increased GLP-1 showed a non-significant tendency to also report increased satiety (OR = 2.95).

Clinical Implications

Further research is necessary to establish long-term effects and practical applications in clinical settings.

Conclusion

Further studies are needed to strengthen the evidence base.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review
  2. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Examining Fiber Supplementation in Prader-Willi Syndrome: Effects on Metabolism and Gut Microbiota Changes
  3. Obesity and Endocrinology, 2025 -- Impact of Antidiabetic Medications on Gut Hormonal Activity Post-Metabolic and Bariatric Surgery: A Comprehensive Review
  4. Obesity Surgery, 2023 -- New Perspectives on Nutrient Detection and Gut-Brain Interaction in the Context of Surgical and Experimental Approaches to Obesity Management
  5. Diabetes Care, 2026 -- Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026
  6. JAMA, 2023 -- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
  7. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  8. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial | Trials | JAMA | JAMA Network

Original Source(s)

Related Content